Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.3 SEK | -0.73% | -5.70% | +14.23% |
Business Summary
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Medical Implants
100.0
%
| 4 | 100.0 % | 9 | 100.0 % | +128.05% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 4 | 100.0 % | 9 | 100.0 % | +128.05% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Forsell
CEO | Chief Executive Officer | 70 | 01/15/01 |
Andreas Öhrnberg
DFI | Director of Finance/CFO | 46 | 01/20/01 |
Director/Board Member | 67 | 01/20/01 | |
Nicole Pehrsson
IRC | Investor Relations Contact | 58 | 01/16/01 |
Henric Forsell
PRN | Corporate Officer/Principal | - | 01/18/01 |
Juliette Cook
LAW | General Counsel | 53 | 01/21/01 |
Amit Kukreja
PRN | Corporate Officer/Principal | 41 | 22/21/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tomas Puusepp
BRD | Director/Board Member | 69 | 01/20/01 |
Liselott Kilaas
CHM | Chairman | 65 | 01/20/01 |
Johan Bojs
BRD | Director/Board Member | 60 | 01/20/01 |
Klaus Neftel
BRD | Director/Board Member | 79 | 01/20/01 |
Director/Board Member | 67 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,125,000,000 | 0 | 0 | 4.863 % |
Stock B | 1 | 58,111,537 | 57,530,421 ( 99.00 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
IMPLANTICA AG 0.05% | 30,000 | 0.05% | 87,818 $ |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.23% | 710M | |
+72.85% | 12.38B | |
-18.60% | 7.92B | |
+16.98% | 7.2B | |
+6.91% | 5.84B | |
+5.99% | 5.07B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-41.33% | 2.23B | |
+0.99% | 2.02B |
- Stock Market
- Equities
- IMP A SDB Stock
- Company Implantica AG